Claritas presented at ASHG 2016

October 27, 2016

Claritas Genomics employees presented three posters at ASHG 2016 in Vancouver, Canada. John Thompson, PhD and Chief Technology Officer, presented on "Improved sensitivity for clinically relevant variants using orthogonal sequencing." Eric White, PhD and Director of Assay and Technology Development, presented on "Improving coverage of poorly sequenced regions in clinical exomes." Natalie Vena, GC and Genetic Counselor Manager, presented a poster entitled, "RIPPLY2: Believe it or not." More posters, publications, and presentations are available in the Resource Center of our website.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.